TP53 and small cell lung carcinoma: As the majority of SCLC patients indicate a lack functional p53, it becomes an attractive target due to the direct involvement in the malignant transformation of tumors.216 Therefore, a study on an antitumor vaccine consisted of dendritic cells transduced with the full-length wild-type P53 gene was conducted for patients with ES-SCLC.